1.Radiation Pneumonitis in Breast Cancer Patients Who Received Radiotherapy Using the Partially Wide Tangent Technique after Breast Conserving Surgery.
Yoonsun CHUNG ; Hong In YOON ; Yong Bae KIM ; Seung Kwon AHN ; Ki Chang KEUM ; Chang Ok SUH
Journal of Breast Cancer 2012;15(3):337-343
PURPOSE: We assessed the risk of radiation pneumonitis (RP) in terms of dosimetric parameters in breast cancer patients, who received radiotherapy using the partially wide tangent technique (PWT), following breast conservation surgery (BCS). METHODS: We analyzed the data from 100 breast cancer patients who underwent radiotherapy using PWT. The entire breast, supraclavicular lymph node, and internal mammary lymph node (IMN) were irradiated with 50.4 Gy in 28 fractions. RP was scored on a scale of 0 to 5, based on Radiation Therapy Oncology Group/European Organization for Research and Treatment of Cancer toxicity criteria. The dosimetric parameters, used in analysis for the ipsilateral lung, were the mean lung dose (MLD), V5 (percentage of lung volume that received a dose of 5 Gy or more)-V50, and normal tissue complication probability (NTCP). RESULTS: Of the 100 patients, three suffered from symptomatic RP (symptom grade > or =2), but were relieved by supportive care. The risk of RP was not correlated with the treatment regimen. RP associated mostly with asymptomatic minimal pulmonary radiologic change or mild dry cough developed more frequently in the group with MLD > or =20.5 Gy or NTCP > or =23% than in the group with MLD <20.5 Gy and NTCP <23% (48.6% vs. 25.4%, p=0.018). CONCLUSION: Dosimetric parameters of MLD and NTCP were correlated with the incidence of RP, but the clinical impact was minimal. We suggest that PWT is a safe technique for the treatment of IMN for BCS patients with low risk of symptomatic RP.
Breast
;
Breast Neoplasms
;
Cough
;
Humans
;
Incidence
;
Lung
;
Lymph Nodes
;
Lymphatic Irradiation
;
Mastectomy, Segmental
;
Radiation Pneumonitis
;
Radiotherapy, Conformal
2.Variants in the Gene EBF2 Are Associated with Kawasaki Disease in a Korean Population.
Yoonsun BAE ; Dongjik SHIN ; Jiho NAM ; Hye Rim LEE ; Jun Sung KIM ; Kyu Yeun KIM ; Dong Soo KIM ; Yeun Jun CHUNG
Yonsei Medical Journal 2018;59(4):519-523
PURPOSE: Kawasaki disease (KD) is a mucocutaneous lymph node syndrome. It is mainly seen in young children under the age of five. KD is a multifactorial disorder that includes genetic variants. The present study investigated the association between KD and single nucleotide polymorphisms (SNPs) in the candidate gene early B cell factor 2 (EBF2), which is associated with inflammation markers. MATERIALS AND METHODS: An SNP analysis was performed by whole exon sequencing of the EBF2 gene. Our study comprised a total of 495 subjects (295 KD patients and 200 unrelated normal controls) from a Korean population. Tag SNPs were discovered using the Haploview program. Genotyping of the EBF2 gene was performed with the TaqMan® assay with real-time PCR methods. RESULTS: Polymorphism of rs10866845 showed a significant difference in allele frequency between KD patients and controls (p=0.040). The EBF2 gene polymorphisms were significantly associated with KD on logistic regression analysis. CONCLUSION: EBF2 gene variants can contribute to KD in the Korean population.
Child
;
Exons
;
Gene Frequency
;
Humans
;
Inflammation
;
Logistic Models
;
Mucocutaneous Lymph Node Syndrome*
;
Polymorphism, Single Nucleotide
;
Real-Time Polymerase Chain Reaction
3.Tissue-specific expression and subcellular localization of ALADIN, the absence of which causes human triple A syndrome.
A Ri CHO ; Keum Jin YANG ; Yoonsun BAE ; Young Yil BAHK ; Eunmin KIM ; Hyungnam LEE ; Jeong Ki KIM ; Wonsang PARK ; Hyanshuk RHIM ; Soo Young CHOI ; Tsuneo IMANAKA ; Sungdae MOON ; Jongbok YOON ; Sungjoo Kim YOON
Experimental & Molecular Medicine 2009;41(6):381-386
Triple A syndrome is a rare genetic disorder caused by mutations in the achalasia-addisonianism-alacrima syndrome (AAAS) gene which encodes a tryptophan aspartic acid (WD) repeat-containing protein named alacrima-achalasia-adrenal insufficiency neurologic disorder (ALADIN). Northern blot analysis shows that the 2.1 kb AAAS mRNA is expressed in various tissues with stronger expression in testis and pancreas. We show that human ALADIN is a protein with an apparent molecular weight of 60 kDa, and expressed in the adrenal gland, pituitary gland and pancreas. Furthermore, biochemical analysis using anti-ALADIN antibody supports the previous finding of the localization of ALADIN in the nuclear membrane. The mutations S544G and S544X show that alteration of S544 residue affects correct targeting of ALADIN to the nuclear membrane.
Adrenal Insufficiency/*genetics
;
Antibodies/immunology
;
Cloning, Molecular
;
DNA, Complementary/genetics
;
Esophageal Achalasia/*genetics
;
Gene Expression Profiling
;
Hela Cells
;
Humans
;
Lacrimal Apparatus Diseases/*genetics
;
Mutagenesis, Site-Directed
;
Nerve Tissue Proteins/*analysis/*genetics/immunology
;
Nuclear Pore/chemistry
;
Nuclear Pore Complex Proteins/*analysis/*genetics/immunology
;
RNA, Messenger/analysis/genetics
;
Syndrome
;
Tissue Distribution